Cytotoxic CD4+ T cells in cancer: an emerging target for next-generation anticancer immunotherapy?
Imke M B van Wandeloo, Kalijn Bol, Carla van Herpen, I Jolanda M de Vries, Gerty Schreibelt · 2025
Read Cytotoxic CD4+ T cells in cancer: an emerging target for next-generation anticancer immunotherapy? by Imke M B van Wandeloo, Kalijn Bol, Carla van Herpen, I Jolanda M de Vries, Gerty Schreibelt (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12730827.txt.
Description
Imke van Wandeloo, Kalijn Bol, Carla van Herpen, Jolanda de Vries, and Gerty Schreibelt reviewed in 2025 a less known kind of immune cell in cancer. Helper T cells were long thought to support other cells rather than kill tumors directly. That killing role was given mainly to a different T cell type.
Recent work shows some helper cells can kill tumor cells directly, using toxic molecules. Such cells have been found in virus infections, immune disorders, and many cancers. The review sets out what these cells look like, how they kill, and what they may mean for care. It also asks how they could be used in new treatments for tumors that carry the needed target marker.
Catalog record
| CREATOR | Imke M B van Wandeloo, Kalijn Bol, Carla van Herpen, I Jolanda M de Vries, Gerty Schreibelt |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 42 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |